Doctor Philpott Approved POLAR POWER MAGNETS "Negative Field" Magnetic Therapy Products. Dr Philpott is widely recognized as the worlds leading authoritiy on the use of biomagnets in magnetic therapy applications for pain relief, disease reversal and magnetic health enhancement. "I don't say that magnets healed you, you say that magnets healed you." William H. Philpott, M.D.
Forget everything you've ever read or heard about magnet therapy in the mainstream that didn't mention the importance of polarity! Polarity is the single most critical factor in the use and application of magnets to the body for healing! (biomagnetics) It is estimated that about 80% of all magnetic therapy products sold today are not proper polarity.
WHAT MAGNETIC THERAPY DOES
The biological response to a static positive magnetic field is acid-hypoxia. The biological response to the static negative magnetic fieldis alkaline-hyperoxia. Positive magnetic field therapy is limited to brief exposure to stimulate neuronal and catabolic glandular functions. Positive magnetic field therapy should be under medical supervision due to the danger of prolonged application, producing acid-hypoxia.
Negative magnetic field therapy has a wide application in such things as cell differentiation, healing, production of adenosine triphosphateby oxidative phosphorylation and processing of toxins by oxidoreductase enzymes and resolution of calcium and amino acid insoluble deposits. Negative magnetic field therapy is not harmful and can effectively be used both under medical supervision and self-help application. Some of the values of magnetic therapy are:
•Enhanced sleep with its health-promoting value by production of melatonin.
•Enhanced healing by production of growth hormone.
•Energy production by virtue of oxidoreductase enzyme production of adenosine triphosphate and catalytic remnant magnetism.
•Detoxification by activation of oxidoreductase enzymes processing free radicals, acids, peroxides, alcohols and aldehydes.
•Pain resolution by replacing acid-hypoxia with alkaline-hyperoxia.
•Reversal of acid-hypoxia degenerative diseases by replacement of acid-hypoxia with alkaline-hyperoxia.
•Antibiotic effect for all types of human invading micro-organisms.
•Cancer remission by virtue of blocking the acid-dependent enzyme function producing ATP by fermentation.
•Resolution of calcium and amino acid insoluble deposits by maintaining alkalinization.
•Neuronal calming providing control over emotional, mental and seizure disorders. “Magnetic therapy has been observed to have the highest predictable results of any therapy I have observed in 40 years of medical practice. ”William H. Philpott, M.D.
ABOUT WILLIAM H. PHILPOTT, M.D. William H. Philpott, M.D. has specialty training and practice in psychiatry, neurology, electroencephalography, nutrition, environmental medicine and toxicology.
JES Organics became a source for the superb American Made Polar Power magnet therapy products because these products were recommended to our founder by her doctor for Lyme Disease and the associated health issues and for her husband's osteoporosis.
Showing posts with label multiple sclerosis. Show all posts
Showing posts with label multiple sclerosis. Show all posts
Wednesday, October 26, 2011
Thursday, June 3, 2010
Basic Information about Lyme Disease
If you have been diagnosed with fibromyalgia, chronic fatigue syndrome, MS, early Alzheimers or early dementia, parkinson's disease or Lou Gerhig's disease, it is recommended that you get tested for Lyme disease. Lyme disease is the great pretender and can mimic these other diseases. Lyme disease is hard to diagnose and lab testing is not reliable. Your best bet for lab testing is IgeneX labs (tick speciality lab).
Basic Information about Lyme Disease
by The International Lyme and Associated Diseases Society
1. Lyme disease is transmitted by the bite of a tick, and the disease is prevalent across the United States and throughout the world. Ticks know no borders and respect no boundaries. A patient's county of residence does not accurately reflect his or her Lyme disease risk because people travel, pets travel, and ticks travel. This creates a dynamic situation with many opportunities for exposure to Lyme disease for each individual.
2. Lyme disease is a clinical diagnosis. The disease is caused by a spiral-shaped bacteria (spirochete) called Borrelia burgdorferi. The Lyme spirochete can cause infection of multiple organs and produce a wide range of symptoms. Case reports in the medical literature document the protean manifestations of Lyme disease, and familiarity with its varied presentations is key to recognizing disseminated disease.
3. Fewer than 50% of patients with Lyme disease recall a tick bite. In some studies this number is as low as 15% in culture-proven infection with the Lyme spirochete.
4. Fewer than 50% of patients with Lyme disease recall any rash. Although the erythema migrans (EM) or “bull’s-eye” rash is considered classic, it is not the most common dermatologic manifestation of early-localized Lyme infection. Atypical forms of this rash are seen far more commonly. It is important to know that the EM rash is pathognomonic of Lyme disease and requires no further verification prior to starting an appropriate course of antibiotic therapy.
5. The Centers for Disease Control and Prevention (CDC) surveillance criteria for Lyme disease were devised to track a narrow band of cases for epidemiologic purposes. As stated on the CDC website, the surveillance criteria were never intended to be used as diagnostic criteria, nor were they meant to define the entire scope of Lyme disease.
6. The ELISA screening test is unreliable. The test misses 35% of culture proven Lyme disease (only 65% sensitivity) and is unacceptable as the first step of a two-step screening protocol. By definition, a screening test should have at least 95% sensitivity.
7. Of patients with acute culture-proven Lyme disease, 20–30% remain seronegative on serial Western Blot sampling. Antibody titers also appear to decline over time; thus while the Western Blot may remain positive for months, it may not always be sensitive enough to detect chronic infection with the Lyme spirochete. For “epidemiological purposes” the CDC eliminated from the Western Blot analysis the reading of bands 31 and 34. These bands are so specific to Borrelia burgdorferi that they were chosen for vaccine development. Since a vaccine for Lyme disease is currently unavailable, however, a positive 31 or 34 band is highly indicative of Borrelia burgdorferi exposure. Yet these bands are not reported in commercial Lyme tests.
8. When used as part of a diagnostic evaluation for Lyme disease, the Western Blot should be performed by a laboratory that reads and reports all of the bands related to Borrelia burgdorferi. Laboratories that use FDA approved kits (for instance, the Mardx Marblot®) are restricted from reporting all of the bands, as they must abide by the rules of the manufacturer. These rules are set up in accordance with the CDCs surveillance criteria and increase the risk of false-negative results. The commercial kits may be useful for surveillance purposes, but they offer too little information to be useful in patient management.
9. There are 5 subspecies of Borrelia burgdorferi, over 100 strains in the US, and 300 strains worldwide. This diversity is thought to contribute to the antigenic variability of the spirochete and its ability to evade the immune system and antibiotic therapy, leading to chronic infection.
10. Testing for Babesia, Anaplasma, Ehrlichia and Bartonella (other tick-transmitted organisms) should be performed. The presence of co-infection with these organisms points to probable infection with the Lyme spirochete as well. If these coinfections are left untreated, their continued presence increases morbidity and prevents successful treatment of Lyme disease.
11. A preponderance of evidence indicates that active ongoing spirochetal infection with or without other tick-borne coinfections is the cause of the persistent symptoms in chronic Lyme disease.
12. There has never been a study demonstrating that 30 days of antibiotic treatment cures chronic Lyme disease. However there is a plethora of documentation in the US and European medical literature demonstrating by histology and culture techniques that short courses of antibiotic treatment fail to eradicate the Lyme spirochete. Short treatment courses have resulted in upwards of a 40% relapse rate, especially if treatment is delayed.
13. Most cases of chronic Lyme disease require an extended course of antibiotic therapy to achieve symptomatic relief. The return of symptoms and evidence of the continued presence of Borrelia burgdorferi indicates the need for further treatment. The very real consequences of untreated chronic persistent Lyme infection far outweigh the potential consequences of long-term antibiotic therapy.
14. Many patients with chronic Lyme disease require prolonged treatment until the patient is symptom-free. Relapses occur and retreatment may be required. There are no tests currently available to prove that the organism is eradicated or that the patient with chronic Lyme disease is cured.
15. Like syphilis in the 19th century, Lyme disease has been called the great imitator and should be considered in the differential diagnosis of rheumatologic and neurologic conditions, as well as chronic fatigue syndrome, fibromyalgia, somatization disorder and any difficult-to-diagnose multi-system illness.
Disclaimer: The foregoing information is for educational purposes only. It is not intended to replace or supersede patient care by a healthcare provider. If an individual suspects the presence of a tick-borne illness, that individual should consult a healthcare provider who is familiar with the diagnosis and treatment of tick-borne diseases.
Basic Information about Lyme Disease
by The International Lyme and Associated Diseases Society
1. Lyme disease is transmitted by the bite of a tick, and the disease is prevalent across the United States and throughout the world. Ticks know no borders and respect no boundaries. A patient's county of residence does not accurately reflect his or her Lyme disease risk because people travel, pets travel, and ticks travel. This creates a dynamic situation with many opportunities for exposure to Lyme disease for each individual.
2. Lyme disease is a clinical diagnosis. The disease is caused by a spiral-shaped bacteria (spirochete) called Borrelia burgdorferi. The Lyme spirochete can cause infection of multiple organs and produce a wide range of symptoms. Case reports in the medical literature document the protean manifestations of Lyme disease, and familiarity with its varied presentations is key to recognizing disseminated disease.
3. Fewer than 50% of patients with Lyme disease recall a tick bite. In some studies this number is as low as 15% in culture-proven infection with the Lyme spirochete.
4. Fewer than 50% of patients with Lyme disease recall any rash. Although the erythema migrans (EM) or “bull’s-eye” rash is considered classic, it is not the most common dermatologic manifestation of early-localized Lyme infection. Atypical forms of this rash are seen far more commonly. It is important to know that the EM rash is pathognomonic of Lyme disease and requires no further verification prior to starting an appropriate course of antibiotic therapy.
5. The Centers for Disease Control and Prevention (CDC) surveillance criteria for Lyme disease were devised to track a narrow band of cases for epidemiologic purposes. As stated on the CDC website, the surveillance criteria were never intended to be used as diagnostic criteria, nor were they meant to define the entire scope of Lyme disease.
6. The ELISA screening test is unreliable. The test misses 35% of culture proven Lyme disease (only 65% sensitivity) and is unacceptable as the first step of a two-step screening protocol. By definition, a screening test should have at least 95% sensitivity.
7. Of patients with acute culture-proven Lyme disease, 20–30% remain seronegative on serial Western Blot sampling. Antibody titers also appear to decline over time; thus while the Western Blot may remain positive for months, it may not always be sensitive enough to detect chronic infection with the Lyme spirochete. For “epidemiological purposes” the CDC eliminated from the Western Blot analysis the reading of bands 31 and 34. These bands are so specific to Borrelia burgdorferi that they were chosen for vaccine development. Since a vaccine for Lyme disease is currently unavailable, however, a positive 31 or 34 band is highly indicative of Borrelia burgdorferi exposure. Yet these bands are not reported in commercial Lyme tests.
8. When used as part of a diagnostic evaluation for Lyme disease, the Western Blot should be performed by a laboratory that reads and reports all of the bands related to Borrelia burgdorferi. Laboratories that use FDA approved kits (for instance, the Mardx Marblot®) are restricted from reporting all of the bands, as they must abide by the rules of the manufacturer. These rules are set up in accordance with the CDCs surveillance criteria and increase the risk of false-negative results. The commercial kits may be useful for surveillance purposes, but they offer too little information to be useful in patient management.
9. There are 5 subspecies of Borrelia burgdorferi, over 100 strains in the US, and 300 strains worldwide. This diversity is thought to contribute to the antigenic variability of the spirochete and its ability to evade the immune system and antibiotic therapy, leading to chronic infection.
10. Testing for Babesia, Anaplasma, Ehrlichia and Bartonella (other tick-transmitted organisms) should be performed. The presence of co-infection with these organisms points to probable infection with the Lyme spirochete as well. If these coinfections are left untreated, their continued presence increases morbidity and prevents successful treatment of Lyme disease.
11. A preponderance of evidence indicates that active ongoing spirochetal infection with or without other tick-borne coinfections is the cause of the persistent symptoms in chronic Lyme disease.
12. There has never been a study demonstrating that 30 days of antibiotic treatment cures chronic Lyme disease. However there is a plethora of documentation in the US and European medical literature demonstrating by histology and culture techniques that short courses of antibiotic treatment fail to eradicate the Lyme spirochete. Short treatment courses have resulted in upwards of a 40% relapse rate, especially if treatment is delayed.
13. Most cases of chronic Lyme disease require an extended course of antibiotic therapy to achieve symptomatic relief. The return of symptoms and evidence of the continued presence of Borrelia burgdorferi indicates the need for further treatment. The very real consequences of untreated chronic persistent Lyme infection far outweigh the potential consequences of long-term antibiotic therapy.
14. Many patients with chronic Lyme disease require prolonged treatment until the patient is symptom-free. Relapses occur and retreatment may be required. There are no tests currently available to prove that the organism is eradicated or that the patient with chronic Lyme disease is cured.
15. Like syphilis in the 19th century, Lyme disease has been called the great imitator and should be considered in the differential diagnosis of rheumatologic and neurologic conditions, as well as chronic fatigue syndrome, fibromyalgia, somatization disorder and any difficult-to-diagnose multi-system illness.
Disclaimer: The foregoing information is for educational purposes only. It is not intended to replace or supersede patient care by a healthcare provider. If an individual suspects the presence of a tick-borne illness, that individual should consult a healthcare provider who is familiar with the diagnosis and treatment of tick-borne diseases.
Tuesday, September 11, 2007
Chronic Stress and Inflammation Increase Disease
Chronic stress and inflammation will take you right over the edge of the cliff as far as disease is concerned—especially if you're already standing on the rim of it. They increase your risk of developing certain neurodegenerative diseases, such as multiple sclerosis, as well as a host of other inflammation-based diseases.
Also, they can elevate the severity of the disease process. Using mice, researchers simulated a chronic-stress situation by placing three young males together for a few weeks. Once the mice had become situated and comfortable living together in this environment, establishing their own natural hierarchy, the researchers then upset the applecart. An aggressive male mouse was introduced into the mix for a couple of hours each night for three consecutive nights. To throw the mice off a bit, they got the next night off from the aggressor before an entirely new aggressor was introduced. This guaranteed that the young mice never knew what to count on next and were in a state of chronic stress. To add to their environmental stress, the mice were given Theiler's murine encephalomyelitis (TMEV)—an infection of the central nervous system that is similar to multiple sclerosis in humans.
The result was an increase in their cytokines (particularly interleukin-6), which is a pro- inflammatory protein that helps the inflammation process along. This cytokine regulates the infection-fighting portion of the immune system. And an increase in this cytokine was found to increase the severity of their infection from the TMEV. This was enough to spur on inflammation, resulting in a weakened early immune response to that infection.
Once the early immune response is affected adversely, the stage has been set for later immune response—which means it will continue to be weak. What this means for you is that whether you are currently dealing with a disease or are simply at risk for one, chronic stress will tip you over the edge. Not only will it make current conditions worse, it can actually fire up the disease process to take hold faster.
I recommend that you master a stress-fighting strategy that works for you. Many community hospitals and colleges offer courses in stress-management techniques, whether they are based on ancient Eastern practices like tai chi and meditation or on a modern-day alternative like biofeedback. Make it a priority to get stress under new management.
Dr. Alan Inglis House Calls
Also, they can elevate the severity of the disease process. Using mice, researchers simulated a chronic-stress situation by placing three young males together for a few weeks. Once the mice had become situated and comfortable living together in this environment, establishing their own natural hierarchy, the researchers then upset the applecart. An aggressive male mouse was introduced into the mix for a couple of hours each night for three consecutive nights. To throw the mice off a bit, they got the next night off from the aggressor before an entirely new aggressor was introduced. This guaranteed that the young mice never knew what to count on next and were in a state of chronic stress. To add to their environmental stress, the mice were given Theiler's murine encephalomyelitis (TMEV)—an infection of the central nervous system that is similar to multiple sclerosis in humans.
The result was an increase in their cytokines (particularly interleukin-6), which is a pro- inflammatory protein that helps the inflammation process along. This cytokine regulates the infection-fighting portion of the immune system. And an increase in this cytokine was found to increase the severity of their infection from the TMEV. This was enough to spur on inflammation, resulting in a weakened early immune response to that infection.
Once the early immune response is affected adversely, the stage has been set for later immune response—which means it will continue to be weak. What this means for you is that whether you are currently dealing with a disease or are simply at risk for one, chronic stress will tip you over the edge. Not only will it make current conditions worse, it can actually fire up the disease process to take hold faster.
I recommend that you master a stress-fighting strategy that works for you. Many community hospitals and colleges offer courses in stress-management techniques, whether they are based on ancient Eastern practices like tai chi and meditation or on a modern-day alternative like biofeedback. Make it a priority to get stress under new management.
Dr. Alan Inglis House Calls
Subscribe to:
Posts (Atom)